Is reducing ovarian volume in polycystic ovarian syndrome patients after administration of metformin associated with improving cardiovascular risk factors?
about
Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseasesMetformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsDoes vitamin D status correlate with clinical and biochemical features of polycystic ovarysyndrome in high school girls?Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome.
P2860
Is reducing ovarian volume in polycystic ovarian syndrome patients after administration of metformin associated with improving cardiovascular risk factors?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Is reducing ovarian volume in ...... g cardiovascular risk factors?
@ast
Is reducing ovarian volume in ...... g cardiovascular risk factors?
@en
type
label
Is reducing ovarian volume in ...... g cardiovascular risk factors?
@ast
Is reducing ovarian volume in ...... g cardiovascular risk factors?
@en
prefLabel
Is reducing ovarian volume in ...... g cardiovascular risk factors?
@ast
Is reducing ovarian volume in ...... g cardiovascular risk factors?
@en
P2093
P2860
P1476
Is reducing ovarian volume in ...... g cardiovascular risk factors?
@en
P2093
Marzie Farimani
Mohsen Gharakhani
Nosrat Neghab
P2860
P577
2011-07-01T00:00:00Z